Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-175451
Filing Date
2018-05-25
Accepted
2018-05-25 16:56:17
Documents
5
Effectiveness Date
2018-05-25

Document Format Files

Seq Description Document Type Size
1 S-8 d528754ds8.htm S-8 74582
2 EX-5.1 d528754dex51.htm EX-5.1 16445
3 EX-23.1 d528754dex231.htm EX-23.1 2303
4 GRAPHIC g528754g03e73.jpg GRAPHIC 2604
5 GRAPHIC g528754g22a63.jpg GRAPHIC 10245
  Complete submission text file 0001193125-18-175451.txt   112450
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225236 | Film No.: 18862213
SIC: 2834 Pharmaceutical Preparations